Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

Journal of Experimental Medicine

Volumn 178, Issue 1, 1993, Pages 27-47

  Chicz, Roman M ^a   Urban, Robert G ^a   Gorga, Joan C ^a,c   Vignali, Dario A A ^a   Lane, William S ^b   Strominger, Jack L ^a  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; CELLULAR IMMUNITY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN PROCESSING;

ALLELES; AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; HLA-DR ANTIGENS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027181070     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.1.27     Document Type: Article

References (96)

1. Rothbard, J.B., and M.L. Gefter. 1991. Interactions between immunogenic peptides and MHC proteins. Amu. Rev. Immunol. 9:527.
2. Bjorkman, P.M., M.A. Saper, B. Samraoui, W.S. Bennett, J.L. Strominger, and D.C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature (Lond.). 329:506.
3. Garrett, T.P.J., M.A. Saper, P.J. Bjorkman, J.L. Strominger, and D.C. Wiley. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature (Lond.). 342:692.
4. Madden, D.R., J.C. Gorga, J.L. Strominger, and D.C. Wiley.1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature (Lond.). 353:321.
5. b molecule. Nature (Lond.). 348:213.
6. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.). 351:290.
7. Jardetzky, T.S., W.S. Lane, R.A. Robinson, D.R. Madden, and D.C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature (Lond.). 353:326.
8. Hunt, D.F., R.A. Henderson, J. Shabanowicz, K. Sakaguchi, H. Michel, N. Sevilir, A. Cox, E. Appella, and V.H. Engelhard. 1992. Characterization of peptides bound to class I MHC molecule HLA-A2.1 by mass spectrometry. Science (Wash. DC). 255:1261.
9. Guo, H.-C., T.S. Jardetzky, T.P.J. Garrett, W.S. Lane, J.L. Strominger, and D.C. Wiley. 1992. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature (Lond.). 360:364.
10. Sadegh-Nasseri, S., and R.N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature (Lond.). 353:167.
11. Jensen, P.E. 1992. Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization. J. Exp Med. 176:793.
12. Rudensky, A.Y., P. Preston-Hurlburt, S.-C. Hong, A. Barlow, and C. A. Janeway. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature (Lond.). 353:622.
13. d. Science (Wash. DC). 256:1817.
14. k. Proc Natl. Acad. Sci. USA. 89:7380.
15. Chicz, R.M., R.G. Urban, W.S. Lane, J.C. Gorga, L.J. Stern, D.A.A. Vignali, and J.L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature (Lond.). 358:764.
16. Gorga, J.C., P.J. Knudsen, J.A. Foran, J.L. Strominger, and S.J. Burakoff. 1986. Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. Cell. Immunol. 103:160.
17. Matsuyama, T., J. Schwenzer, J. Silver, and R.J. Winchester. 1986. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. J. Immunol. 137:934.
18. Gorga, J.C., V. Horejsi, D.R. Johnson, R. Raghupathy, and J.L. Strominger. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262:16087.
19. Gorga, J.C., J.H. Brown, T. Jardetzky, D.C. Wiley, and J.L. Strominger. 1991. Crystallization of HLA-DR antigens. Res. Immunol. 142:401.
20. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680.
21. Lane, W.S., A. Galat, M.W. Harding, and S.L. Schreiber. 1991. Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. T. Protein Chem. 10:151.
22. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403.
23. Busch, R., G. Strang, K. Howland, and J.B. Rothbard. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443.
24. Hill, C.M., J.D. Hayball, A.A. Allison, and J.B. Rothbard. 1991. Conformational and structural characteristics of peptides binding to HLA-DR molecules. J. Immunol. 147:189.
25. Springer, T.A., J.F. Kaufman, L.A. Siddoway, D.L. Mann, and J.L. Strominger. 1977. Purification of HLA-linked B lymphocyte alloantigens in the immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. J. Biol. Chem. 252:6201.
26. Dommair, K., B. Rothenhausler, and H.M. McConnell. 1989. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harbor Symp Quant. Biol. 54:409.
27. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387.
28. Bachvaroff, R.J., F. Miller, and F.T. Rapaport. 1980. Appearance of cytoskeletal components on the surface of leukemia cells and of lymphocytes transformed by mitogens and Epstein-Barr virus. Proc Natl. Acad. Sci. USA. 77:4979.
29. Cheng, Y.-S.E., C.E. Patterson, and P. Staeheli. 1991. Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol. Cell. Biol. 11:4717.
30. Bourne, H.R. 1988. Do GTPases direct membrane traffic in secretion? Cell. 53:669.
31. Colombo, M.I., L.S. Mayorga, P.J. Casey, and P.D. Stahl. 1992. Evidence of a role for heterotrimeric GTP-binding proteins in endosome fusion. Science (Wash. DC). 255:1695.
32. DeNagel, D.C., and S.K. Pierce. 1992. A case for chaperones in antigen processing. Immunol. Today. 13:86.
33. Sinigaglia, F., M. Guttinger, J. Kilgus, D.M. Doran, H. Ma-tile, H. Etlinger, A. Trzeciak, D. Gillessen, and J.R.L. Pink. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature (Lond.). 336:778.
34. Guttinger, M., P. Romagnoli, L. Vandel, R. Meloen, B. Takacs, J.R.L. Pink, and F. Sinigaglia. 1991. HLA polymorphism and T cell recognition of a conserved region of pl90, a malaria vaccine candidate. Int. Immunol. 3:899.
35. Lamb, J.R., A.D.M. Rees, V. Bal, H. Ikeda, D. Wilkinson, R.R.P. De Vries, and J.B. Rothbard. 1988. Prediction and identification of an HLA-DR-restricted T cell determinant in the 19-kDa protein of Mycobacterium tuberculosis. Eur. J. Immunol. 18:973.
36. Roche, P.A., and P. Cresswell. 1990. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J. Immunol. 144:1849.
37. O’Sullivan, D., J. Sidney, E. Appella, L. Walker, L. Phillips, S.M. Colon, C. Miles, R.W. Chesnut, and A. Sette. 1990. Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol. 145:1799.
38. O’Sullivan, D., J. Sidney, M.-F. Del Guercio, S.M. Colon, and A. Sette. 1991. Truncation analysis of several DR binding epitopes. J. Immunol. 146:1240.
39. O’Sullivan, D., T. Arrhenius, J. Sidney, M.-F. Del Guercio, M. Albertson, M. Wall, C. Oseroffi S. Southwood, S.M. Colon, F.C. A. Gaeta, and A. Sette. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol. 147:2663.
40. Sette, A., A. Vitiello, P. Famess, J. Furze, J. Sidney, J.M. Claverie, H.M. Grey, and R. Chesnut. 1991. Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules. J. Immunol. 147:3893.
41. Bjorkman, P.J., and P. Parham. 1990. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59:253.
42. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an FILA-A, -B, -C null human cell line. J. Immunol. 142:3320.
43. Jardetzky, T.S., J.C. Gorga, R. Busch, J. Rothbard, J.L. Strominger, and D.C. Wiley. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO(Eur. Mol. Biol. Organ.)J. 9:1797.
44. Krieger, J.I., R.W. Karr, H.M. Grey, W.-Y. Yu, D. O’Sullivan, L. Batovsky, Z.-L. Zheng, S.M. Colon, F.C.A. Gaeta, J. Sidney, M. Albertson, M.-F. Del Guercio, R.W. Chesnut, and A. Sette. 1991. Single amino acid changes in DR and antigen define residues crucial for peptide-MHC binding and T cell recognition. J. Immunol. 146:2331.
45. Hammer, J., B. Takacs, and F. Sinigaglia. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp Med. 176:1007.
46. Newcomb, J.F., and P. Cresswell. 1993. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J. Immunol. 150:499.
47. Unanue, E.R., and J.-C. Cerottini. 1989. Antigen presentation. FASEB (Fed. Am. Soc Biol. Organ.) J. 3:2496.
48. Jin, Y., J.W.-K. Shih, and I. Berkower. 1988. Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J. Exp Med. 168:293.
49. Weiss, S., and B. Bogen. 1989. B lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc Natl. Acad. Sci. USA. 86:282.
50. Eisenlohr, L.C., and C.J. Hackett. 1989. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis. J Exp Med. 169:921.
51. Nuchtem, J.G., W.E. Biddison, and R.D. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature (Lond.). 343:74.
52. + cytotoxic T cell recognition of endogenously processed antigen. J. Immunol. 144:2789.
53. Chen, B.P., A. Madrigal, and P. Parham. 1990. Cytotoxic T cell recognition of an endogenous class IHLA peptide presented by a class II HLA molecule. J. Exp Med. 172:779.
54. Weiss, S., and B. Bogen. 1991. MHC class II-restricted presentation of intracellular antigen. Cell. 64:767.
55. Moreno, J., D.A.A. Vignali, F. Nadimi, S. Fuchs, L. Adorini, and GJ. Hammerling. 1991. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J. Immunol. 147:3306.
56. Jaraquemada, D., M. Marti, and E.O. Long. 1990. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp Med. 172:947.
57. Malnati, M.S., M. Marti, T. LaVaute, D. Jaraquemada, W. Biddison, R. DeMars, and E.O. Long. 1992. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature (Lond.). 357:702.
58. De Koster, H.S., D.C. Anderson, and A. Termijtelen. 1989. T cells sensitized to synthetic HL A-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J. Exp Med. 169:1191.
59. Liu, Z., Y.-K. Sun, Y.-P. Xi, P. Harris, and N. Suciu-Foca. 1992. T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules. J. Exp Med. 175:1663.
60. Rudensky, A.Y., P. Preston-Hurlburt, B.K. Al-Ramadi, J. Rothbard, and C.A. Janeway, Jr. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature (Lond.). 359:429.
61. Rothbard, J.B., and W.R. Taylor. 1988. A sequence pattern common to T cell epitopes. EMBO (Eur. Mol. Biol. Organ.) J. 7:93.
62. Donermeyer, D.L., and P.M. Allen. 1989. Binding to la protects an immunogenic peptide from proteolytic degradation. J. Immunol. 142:1063.
63. Mouritsen, S., M. Meldal, O. Werdelin, A. Stryhn Hansen, and S. Buus. 1992. MHC molecules protect T cell epitopes against proteolytic destruction. J. Immunol. 149:1987.
64. Ishioka, G.Y., A.G. Lamont, D. Thomson, N. Bulbow, F.C.A. Gaeta, A. Sette, and H.M. Grey. 1992. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J. Immunol. 148:2446.
65. Harding, C.V., D.S. Collins, J.W. Slot, H.J. Geuze, and E.R. Unanue. 1991. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell. 64:393.
66. Collins, D.S., E.R. Unanue, and C.V. Harding. 1991. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol. 147:4054.
67. Van Noort, J.M., J. Boon, A.C.M. Van der Drift, J.P.A. Wagenaar, A.M.H. Boots, and C.J.P. Boog. 1991. Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells. Eur. J. Immunol. 21:1989.
68. Cresswell, P. 1985. Intracellular class II antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated-endocytosis. Proc Natl. Acad. Sci. USA. 82:8188.
69. Neefjes, J.J., V. Stollorz, P.J. Peters, H.J. Geuze, and H.L. Ploegh. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell. 61:171.
70. Peters, P.J., J.J. Neeles, V. Oorschot, H.L. Ploegh, and H.J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (Lond.). 349:669.
71. Knott, T.J., R.J. Pease, L.M. Powell, S.C. Wallis, S.C. Rail, Jr., T.L. Innerarity, B. Blackhart, W.H. Taylor, Y. Marcel, R. Milne et al. 1986. Complete protein sequence and identification of structural domains of human apolipoprotein R Nature (Lond.). 323:734.
72. Harding, C.V., and E.R. Unanue. 1990. Quantitation of antigen-processing cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (Lond.). 346:574.
73. Demotz, S., H.M. Grey, and A. Sette. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science (Wish. DC). 249:1028.
74. Suzuki, G., Y. Kawase, S. Koyasu, I. Yahara, Y. Kobayashi, and R.H. Schwartz. 1988. Antigen-induced suppression of the proliferative response of T cell clones. J. Immunol 140:1359.
75. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249.
76. + T cells in mice tolerant to Staphylococcus aureus enterotaxin B. Nature (Lond.). 349:245.
77. Rocha, B., and H. von Boehmer. 1991. Peripheral selection of the T cell repertoire. Science (Wash. DC). 251:1225.
78. Miller, J.F.A.P., and G. Morahan. 1992. Peripheral T cell tolerance. Annu. Rev. Immunol. 10:51.
79. Anderson, M.S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility molecules. Proc Natl. Acad. Sci. USA. 89:2282.
80. Roche, P.A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature (Lond.). 345:615.
81. Roche, P.A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl. Acad. Sci. USA. 88:3150.
82. Claesson-Welsh, L., and P.A. Peterson. 1985. Implications of the invariant gamma-chain on the intracellular transport of class II histocompatibility antigens. J. Immunol. 135:3551.
83. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707.
84. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S.L. Schmid, V. Quaranta, and P.A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature (Lond). 348:600.
85. Teyton, L., D. O’Sullivan, P.W. Dickson, V. Lotteau, A. Sette, P. Fink, and P.A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature (Lond.). 348:39.
86. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature (Lond.). 357:596.
87. Sette, A., S. Ceman, R.T. Kubo, K. Sakaguchi, E. Appella, D.F. Hunt, T.A. Davis, H. Michel, J. Shabanowitz, R. Rudersdorf, H.M. Grey, and R. DeMars. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science (Wash. DC). 258:1801.
88. Riberdy, J.M., J.R. Newcomb, M.J. Surman, J.A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules from an antigenprocessing mutant cell line are associated with invariant chain peptides. Nature (Lond.). 360:474.
89. Holmes, N., and P. Parham. 1985. Exxon shuffling in vivo can generate novel HLA class I molecules. EMBO (Eur. Mol. Biol. Organ.) J. 4:2849.
90. Matsumura, M., D.H. Fremont, P.A. Peterson, and I.A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science (Wash. DC). 257:927.
91. b molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc Natl. Acad. Sci. USA. 89:8403.
92. Silver, M.L., H.-C. Guo, J.L. Strominger, and D.C. Wiley. 1992. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature (Lond.). 360:367.
93. Kropshofer, H., H. Max, C.A. Muller, F. Hesse, S. Stevanovic, G. Jung, and H. Kalbacher. 1992. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue motif. J. Exp Med. 175:1799.
94. Geluk, A., A.A.M. Janson, J. Wouter Drijfhout, R.H. Meloen, R.R.P. De Vries, and T.H.M. Ottenhoff. 1992. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J. Immunol. 149:2864.
95. Sidney, J., C. Oseroff, S. Southwood, M. Wall, G. Ishioka, F. Korning, and A. Sette. 1992. DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DRβ1 alleles. J. Immunol. 149:2634.
96. Brown, J.H., T. Jardetzky, M.A. Saper, B. Samraoui, P.J. Bjorkman, and D.C. Wiley. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (Lond.). 332:845.